Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin

Yanan Li,1 Pengcheng Xu,1 Dongsheng He,1 Bohui Xu,2 Jiasheng Tu,1 Yan Shen1 1China Pharmaceutical University, Center for Research Development and Evaluation of Pharmaceutical Excipients and Generic Drugs, Nanjing 210009, People’s Republic of China; 2School of Pharmacy, Nantong University,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li Y, Xu P, He D, Xu B, Tu J, Shen Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/d64bb162c2e74ffd8b547d63e12e43b2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d64bb162c2e74ffd8b547d63e12e43b2
record_format dspace
spelling oai:doaj.org-article:d64bb162c2e74ffd8b547d63e12e43b22021-12-02T12:41:12ZLong-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin1178-2013https://doaj.org/article/d64bb162c2e74ffd8b547d63e12e43b22020-09-01T00:00:00Zhttps://www.dovepress.com/long-circulating-thermosensitive-liposomes-for-the-targeted-drug-deliv-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yanan Li,1 Pengcheng Xu,1 Dongsheng He,1 Bohui Xu,2 Jiasheng Tu,1 Yan Shen1 1China Pharmaceutical University, Center for Research Development and Evaluation of Pharmaceutical Excipients and Generic Drugs, Nanjing 210009, People’s Republic of China; 2School of Pharmacy, Nantong University, Nantong 226001, People’s Republic of ChinaCorrespondence: Yan Shen Tel/Fax +86-25-83271305Email shenyan@cpu.edu.cnIntroduction: Oxaliplatin (L-OHP) is a well-known third-generation platinum anticancer drug with severe systemic- and neuro-toxicity. The main objective of the current research was to develop a targeted long-circulating thermosensitive smart-release liposome (LCTL) system for better therapeutic efficacy and less toxicity.Methods: The reverse-phase evaporation method (REV) was used to prepare L-OHP loaded LCTL (L-OHP/LCTL). The physical characteristics were evaluated including encapsulation efficiency (EE), size, zeta potential and stability. The release behavior, cytotoxicity and in vivo evaluation were also carried out.Results: EE of LCTL was around 25% with a uniform size distribution, and LCTL achieved almost complete release at 42°C while it was only 10% at 37°C. Moreover, the LCTL showed significantly higher cytotoxicity at 42°C than that at 37°C. The in vivo results indicated LCTL could target tumors and enhance retention for more than 24 h, thereby enhancing anti-tumor efficacy on 4T1-bearing mice.Discussion: These results indicated that LCTL not only possessed a prolonged circulation time but it also enhanced accumulation and achieved selective release at the tumor sites. Conclusively, LCTL could serve as a promising carrier for oxaliplatin delivery to treat solid tumors.Keywords: delivery, oxaliplatin, thermosensitive, pharmacokinetic properties, tumor targetingLi YXu PHe DXu BTu JShen YDove Medical Pressarticledeliveryoxaliplatinthermosensitivepharmacokinetic propertiestumor targetingMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 6721-6734 (2020)
institution DOAJ
collection DOAJ
language EN
topic delivery
oxaliplatin
thermosensitive
pharmacokinetic properties
tumor targeting
Medicine (General)
R5-920
spellingShingle delivery
oxaliplatin
thermosensitive
pharmacokinetic properties
tumor targeting
Medicine (General)
R5-920
Li Y
Xu P
He D
Xu B
Tu J
Shen Y
Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
description Yanan Li,1 Pengcheng Xu,1 Dongsheng He,1 Bohui Xu,2 Jiasheng Tu,1 Yan Shen1 1China Pharmaceutical University, Center for Research Development and Evaluation of Pharmaceutical Excipients and Generic Drugs, Nanjing 210009, People’s Republic of China; 2School of Pharmacy, Nantong University, Nantong 226001, People’s Republic of ChinaCorrespondence: Yan Shen Tel/Fax +86-25-83271305Email shenyan@cpu.edu.cnIntroduction: Oxaliplatin (L-OHP) is a well-known third-generation platinum anticancer drug with severe systemic- and neuro-toxicity. The main objective of the current research was to develop a targeted long-circulating thermosensitive smart-release liposome (LCTL) system for better therapeutic efficacy and less toxicity.Methods: The reverse-phase evaporation method (REV) was used to prepare L-OHP loaded LCTL (L-OHP/LCTL). The physical characteristics were evaluated including encapsulation efficiency (EE), size, zeta potential and stability. The release behavior, cytotoxicity and in vivo evaluation were also carried out.Results: EE of LCTL was around 25% with a uniform size distribution, and LCTL achieved almost complete release at 42°C while it was only 10% at 37°C. Moreover, the LCTL showed significantly higher cytotoxicity at 42°C than that at 37°C. The in vivo results indicated LCTL could target tumors and enhance retention for more than 24 h, thereby enhancing anti-tumor efficacy on 4T1-bearing mice.Discussion: These results indicated that LCTL not only possessed a prolonged circulation time but it also enhanced accumulation and achieved selective release at the tumor sites. Conclusively, LCTL could serve as a promising carrier for oxaliplatin delivery to treat solid tumors.Keywords: delivery, oxaliplatin, thermosensitive, pharmacokinetic properties, tumor targeting
format article
author Li Y
Xu P
He D
Xu B
Tu J
Shen Y
author_facet Li Y
Xu P
He D
Xu B
Tu J
Shen Y
author_sort Li Y
title Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
title_short Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
title_full Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
title_fullStr Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
title_full_unstemmed Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
title_sort long-circulating thermosensitive liposomes for the targeted drug delivery of oxaliplatin
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/d64bb162c2e74ffd8b547d63e12e43b2
work_keys_str_mv AT liy longcirculatingthermosensitiveliposomesforthetargeteddrugdeliveryofoxaliplatin
AT xup longcirculatingthermosensitiveliposomesforthetargeteddrugdeliveryofoxaliplatin
AT hed longcirculatingthermosensitiveliposomesforthetargeteddrugdeliveryofoxaliplatin
AT xub longcirculatingthermosensitiveliposomesforthetargeteddrugdeliveryofoxaliplatin
AT tuj longcirculatingthermosensitiveliposomesforthetargeteddrugdeliveryofoxaliplatin
AT sheny longcirculatingthermosensitiveliposomesforthetargeteddrugdeliveryofoxaliplatin
_version_ 1718393769248686080